D.A. Davidson & Co’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Buy
14,707
+400
+3% +$31.5K 0.01% 916
2025
Q4
$1.17M Buy
14,307
+183
+1% +$14.3K 0.01% 834
2025
Q3
$1.06M Buy
14,124
+8,585
+155% +$640K 0.01% 851
2025
Q2
$410K Sell
5,539
-3,432
-38% -$239K ﹤0.01% 1130
2025
Q1
$724K Buy
8,971
+12
+0.1% +$1.03K 0.01% 885
2024
Q4
$700K Buy
8,959
+4,237
+90% +$360K 0.01% 899
2024
Q3
$443K Sell
4,722
-292
-6% -$24.5K ﹤0.01% 1060
2024
Q2
$391K Sell
5,014
-736
-13% -$60K ﹤0.01% 1076
2024
Q1
$523K Buy
5,750
+746
+15% +$62.1K ﹤0.01% 972
2023
Q4
$387K Sell
5,004
-784
-14% -$54.9K ﹤0.01% 1040
2023
Q3
$394K Sell
5,788
-4,487
-44% -$326K ﹤0.01% 989
2023
Q2
$835K Sell
10,275
-1,262
-11% -$101K 0.01% 746
2023
Q1
$946K Buy
+11,537
New +$824K 0.01% 695

Other funds holding GEHC

D.A. Davidson & Co's GEHC Position: Q1 2026 in Review

D.A. Davidson & Co increased its GE HealthCare (GEHC) stake by 2.8% in Q1 2026, buying an estimated $31.5K and bringing the position to 14,707 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #916.

D.A. Davidson & Co first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.17M in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • D.A. Davidson & Co held 14,707 shares of GE HealthCare worth $1.05M as of Q1 2026.
  • D.A. Davidson & Co bought 400 GE HealthCare shares in Q1 2026, an estimated $31.5K.
  • GE HealthCare made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #916 holding.
  • D.A. Davidson & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • D.A. Davidson & Co's GE HealthCare position peaked at $1.17M in Q4 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.